New Treatment Yields Complete Regression Of A Human Cancer In Mice
Medical News Today (press release), UK -Enzon Pharmaceuticals' David Filpula and colleagues at the National Cancer Institute worked on SS1P, a so-called immunotoxin that targets and destroys cells ...